Dr Daniel Ford

Dr Dan Ford is a Clinical Oncologist specialising in prostate, bladder and kidney cancers. He is a previous Clinical Service Lead for oncology and radiotherapy at University Hospital Birmingham, the major regional referral service. Dr Ford is actively involved in and deeply committed to cancer research. He is a deputy clinical cancer lead for the West Midlands NIHR Clinical Research Network, whose role is to support and promote research activity across the region. His work includes being the local lead of the PACE trial looking at profound hypofractionation techniques for localised prostate cancer and helping to advance SABR (stereotactic ablative radiotherapy), precision technology originally developed for brain and lung cancer, now being applied to other areas such as metastatic prostate cancer. He is experienced in providing and evaluating all oncological treatments for prostate, kidney and bladder cancer including prostate brachytherapy. After completing his medical degree at the University of Birmingham and post graduate training in the region, Dr Ford completed specialist training in prestigious London teaching hospitals before returning to the West Midlands where he has been a consultant for over 13 years.

Oncological treatment of all urological malignancies including prostate, bladder and kidney cancer. <ul> <li> Radiotherapy including SABR, external beam and MRLinac </li> <li> Hormonal, chemotherapy, immunotherapy and other treatments for urological cancers </li> </ul>